BioSante Bio-E-Gel Transdermal Estradiol Is Firm’s First NDA
This article was originally published in The Pink Sheet Daily
Executive Summary
BioSante is seeking approval of Bio-E-Gel for treatment of moderate-to-severe hot flashes in menopausal women.